期刊
BIOMEDICINES
卷 11, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11020435
关键词
nanomedicine; liposomes; therapeutic effect; clinical trials
Nanomedicine, through the use of nanosized tools, specifically liposomes, has shown great potential in the diagnosis, prevention, and treatment of diseases. Liposomes, as biodegradable and biocompatible nanosystems, have a wide range of applications in disease management, analgesia, vaccination, diagnostics, and immunosuppression in organ transplantation. Furthermore, liposomes have already been successfully used in clinical trials as effective and safe nanomedicine tools.
Nanomedicine, a promising area of medicine, employs nanosized tools for the diagnosis, prevention, and treatment of disease. Particularly, liposomes, lipid-based nanovesicles, are currently one of the most successful nanosystems, with extensive applications in the clinic and an increasing pipeline of products in preclinical and clinical development. These versatile nanotechnological tools are biocompatible and biodegradable, and can load a variety of molecules and, ultimately, improve the therapeutic performance of drugs while minimizing undesired side effects. In this review, we provide a brief description on liposomes' composition and classification and mainly focus on their clinical use in various areas, including disease management (e.g., cancer, fungal and bacterial infections, ocular pathologies), analgesia, vaccination, diagnostics, and immunosuppression in organ transplantation. Herein are described examples of current liposomal products already in the clinic, as well as the most recent clinical trials involving liposomes as effective and safe nanomedicine tools.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据